The Pediatric Infectious Disease Journal · 1997 · 67 citations · 20 references
PharmacyPediatricsPharmacotherapyAntimicrobial PharmacotherapyPediatric Infectious DiseasesPediatric PharmacotherapyCystic FibrosisCystic Fibrosis PharmacotherapyPediatric Antibiotic TherapyPediatric Antimicrobial TherapyPediatric Clinical TrialsPediatric PharmacologyPediatric Cystic Fibrosis PharmacotherapyPulmonary ExacerbationsSerious Adverse Events
BACKGROUND: More data on the efficacy and safety of ciprofloxacin in pediatric cystic fibrosis patients are needed. METHODS: One hundred eight pediatric cystic fibrosis patients (ages 5 to 17 years) with acute bronchopulmonary exacerbations entered a randomized multicenter trial designed to compare the safety and efficacy of antipseudomonas therapy with oral ciprofloxacin (15 mg/kg twice daily; maximum dosage 750 mg twice daily) or intravenous ceftazidime plus tobramycin (CAZ/TM) for 14 days. RESULTS: Clinical improvement was observed in 93% of patients treated with oral ciprofloxacin and in 96% of those receiving parenteral therapy. Transient suppression of Pseudomonas aeruginosa was achieved in 63% of patients at the end of the course of iv CAZ/TM therapy and in 24% receiving ciprofloxacin. Ultrasound examination and nuclear magnetic resonance imaging scans showed no evidence of cartilage toxicity in any of the ciprofloxacin-treated patients. Musculoskeletal adverse events were reported with similar frequency in the two groups of patients (7% in the group receiving ciprofloxacin therapy and 11% in the IV CAZ/TM group). The only sustained musculoskeletal symptom was a case of synovitis in a patient receiving parenteral CAZ/TM. CONCLUSION: Ciprofloxacin thus appears to be safe and effective for use in young patients with bronchopulmonary exacerbation of cystic fibrosis.
20
MICROBIOLOGY OF LUNG INFECTIONS IN CYSTIC FIBROSIS PATIENTS
Niels Høiby · Acta Paediatrica · 1982 · 228 citations
ORAL CIPROFLOXACIN THERAPY OF INFECTIONS DUE TO PSEUDOMONAS AERUGINOSA
BrianE. Scully, MichaelF. Parry, HaroldC. Neu et al. · The Lancet · 1986 · 156 citations
Veterinary Medicine, Infectious Diseases, Pharmacotherapy +14
Cartilage disorders: comparison of spin-echo, CHESS, and FLASH sequence MR images.
H. König, R. Sauter, M. Deimling et al. · Radiology · 1987 · 148 citations
Arthropathy induced by antibacterial fused N-alkyl-4-pyridone-3-carboxylic acids
Brian Ingham, D. W. Brentnall, Eugenie A. Dale et al. · Toxicology Letters · 1977 · 144 citations